Ceftriaxone Induced Biliary Pseudolithiasis in Children: Report of 14 Cases

Objective: Biliary pseudolithiasis has been reported in patients who received ceftriaxone therapy. In this study we evaluated children with ceftriaxone associated pseudolithiasis that was discovered incidentally in US examination.Material Methods: The study includes 14 children with gallstones in Ultrasound without biliary symptoms with recent ceftriaxone administration. All of them were treated for suspected or definite bacterial infection with ceftriaxone 50-100mg/kg/day divided into 2 equal intravenous doses under conditions of adequate hydration. There were no other known underlying diseases for gallstone.Findings: Fourteen patients (11 boys and 3 girls) with mean age of 4.5 years (range: 2 months to 14 years) were studied. Following cessation of treatment with ceftriaxone, a complete resolution of the lithiasis was seen in most of followed cases. All patients were free from biliary symptoms (Right upper quadrant pain, Cholestasis) during observation. Consultations with surgeon or subspecialist due to reported gallstone in the Ultrasound were performed in about two-thirds of patients.Conclusion: Development of pseudolithiasis after ceftriaxone administration is not uncommon and should be known by pediatricians and radiologists in order to avoid unnecessary surgery or additional consultations.